Excellent! I have very rich classification data. Now I have enough information to compile a comprehensive, exam-oriented pharmacology classification guide in the style of KD Tripathi. Let me now write the complete answer.
Important Drug Classifications in Pharmacology
(KD Tripathi Style - UG Exam Focus)
Below are the most exam-important drug classifications, organized by system. These are the ones KDT emphasizes and examiners repeatedly ask.
1. AUTONOMIC NERVOUS SYSTEM DRUGS
Adrenergic Agonists (Sympathomimetics)
| Type | Mechanism | Drugs |
|---|
| Direct-acting | Act on adrenergic receptors | Adrenaline, Noradrenaline, Isoprenaline, Dobutamine, Salbutamol, Clonidine |
| Indirect-acting | Release stored NE | Amphetamine, Tyramine, Ephedrine (partial) |
| Mixed-acting | Both direct + indirect | Ephedrine, Dopamine |
Receptor selectivity:
- α1 selective: Phenylephrine, Methoxamine, Xylometazoline
- α2 selective: Clonidine, Methyldopa (pro-drug), Brimonidine
- β1 selective: Dobutamine, Metaraminol
- β2 selective: Salbutamol, Terbutaline, Salmeterol, Formoterol, Ritodrine
- Non-selective β: Isoprenaline
- Non-selective α+β: Adrenaline (low dose α+β; high dose: α>β), Noradrenaline (α>β)
- Dopamine: D1 > β1 > α1 (dose-dependent)
Adrenergic Antagonists (Sympatholytics)
Alpha-blockers:
| Class | Drugs |
|---|
| Non-selective α (irreversible) | Phenoxybenzamine |
| Non-selective α (competitive) | Phentolamine, Tolazoline |
| Selective α1 | Prazosin, Terazosin, Doxazosin, Tamsulosin |
| Selective α2 | Yohimbine |
Beta-blockers:
| Class | Drugs |
|---|
| Non-selective β (no ISA) | Propranolol, Timolol, Nadolol, Sotalol |
| Non-selective β (with ISA) | Pindolol, Oxprenolol |
| Cardioselective β1 (no ISA) | Metoprolol, Atenolol, Bisoprolol, Esmolol |
| Cardioselective β1 (with ISA) | Acebutolol |
| α + β blocker | Labetalol, Carvedilol |
Cholinergic Drugs
Cholinomimetics:
| Class | Drugs |
|---|
| Choline esters (direct) | Acetylcholine, Carbachol, Bethanechol, Methacholine |
| Alkaloids (direct) | Muscarine, Pilocarpine, Arecoline |
| Anticholinesterases (indirect - reversible) | Physostigmine, Neostigmine, Pyridostigmine, Edrophonium |
| Anticholinesterases (indirect - irreversible) | Organophosphates: Malathion, Parathion, Tabun, DFP (Dyflos) |
Anticholinergics (Muscarinic blockers):
| Use | Drugs |
|---|
| General | Atropine, Hyoscine (Scopolamine), Homatropine |
| Antispasmodics (GI) | Dicyclomine, Propantheline, Glycopyrrolate |
| Anti-Parkinson | Trihexyphenidyl (Benzhexol), Biperiden, Procyclidine |
| Pre-anesthetic | Glycopyrrolate, Atropine |
| Bronchodilator | Ipratropium, Tiotropium |
2. CNS DRUGS
Sedative-Hypnotics
| Class | Drugs |
|---|
| Benzodiazepines (short-acting) | Triazolam, Oxazepam, Temazepam |
| Benzodiazepines (long-acting) | Diazepam, Chlordiazepoxide, Nitrazepam, Flurazepam |
| Barbiturates (ultra-short) | Thiopentone, Methohexitone |
| Barbiturates (short) | Pentobarbitone, Secobarbitone |
| Barbiturates (long) | Phenobarbitone |
| Z-drugs (non-BZD) | Zolpidem, Zopiclone, Zaleplon |
| Newer hypnotics | Melatonin, Ramelteon, Doxepin |
Antiepileptics (KDT Classification)
| Type of Seizure | Drug of Choice | Alternatives |
|---|
| Tonic-clonic (GTCS) | Sodium valproate, Phenytoin | Carbamazepine, Phenobarbitone |
| Absence (Petit mal) | Ethosuximide | Sodium valproate, Clonazepam |
| Myoclonic | Sodium valproate | Clonazepam, Levetiracetam |
| Focal/Partial | Carbamazepine | Phenytoin, Valproate, Lamotrigine |
| Status epilepticus | IV Diazepam / Lorazepam → Phenytoin → Phenobarbitone | Levetiracetam, Propofol |
| Febrile seizures | Diazepam (rectal/IV) | Phenobarbitone |
Mechanism-based classification:
- Na+ channel blockers: Phenytoin, Carbamazepine, Lamotrigine, Oxcarbazepine
- GABA enhancers: Phenobarbitone, Benzodiazepines, Gabapentin, Vigabatrin, Tiagabine
- T-type Ca2+ channel blockers: Ethosuximide
- Multiple mechanisms (valproate): Na+ block + GABA ↑ + T-Ca2+ block
Antipsychotics (Neuroleptics)
| Generation | Drugs |
|---|
| Typical / FGA (low potency) | Chlorpromazine, Thioridazine |
| Typical / FGA (high potency) | Haloperidol, Fluphenazine, Trifluoperazine |
| Atypical / SGA | Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Ziprasidone |
| Depot (long-acting) | Fluphenazine decanoate, Haloperidol decanoate, Risperidone microspheres |
Antidepressants
| Class | Drugs |
|---|
| TCAs | Imipramine, Amitriptyline, Clomipramine, Desipramine |
| SSRIs | Fluoxetine, Sertraline, Paroxetine, Escitalopram, Fluvoxamine |
| SNRIs | Venlafaxine, Duloxetine |
| MAOIs | Phenelzine, Tranylcypromine, Moclobemide (reversible - RIMA) |
| Atypicals | Mirtazapine (NaSSA), Bupropion (NDRI), Trazodone |
Opioid Analgesics
| Class | Drugs |
|---|
| Strong agonists (μ) | Morphine, Fentanyl, Methadone, Meperidine (Pethidine), Oxycodone |
| Moderate agonists | Codeine, Tramadol, Tapentadol, Dihydrocodeine |
| Mixed agonist-antagonist | Pentazocine (κ agonist/μ antagonist), Buprenorphine (partial μ agonist), Nalbuphine |
| Pure antagonists | Naloxone (short-acting), Naltrexone (long-acting), Methylnaltrexone (peripheral) |
3. CARDIOVASCULAR DRUGS
Antihypertensives (KDT Classification)
| Class | Drugs |
|---|
| Diuretics | Thiazides (Hydrochlorothiazide), Loop (Furosemide), K-sparing (Spironolactone, Amiloride) |
| ACE Inhibitors | Captopril (sulfhydryl), Enalapril, Lisinopril, Ramipril (carboxyl), Fosinopril (phosphinyl) |
| ARBs (sartans) | Losartan, Valsartan, Irbesartan, Telmisartan, Candesartan |
| CCBs - Dihydropyridines | Nifedipine, Amlodipine, Felodipine, Nimodipine |
| CCBs - Non-DHP | Verapamil (phenylalkylamine), Diltiazem (benzothiazepine) |
| β-blockers | Atenolol, Metoprolol, Propranolol |
| Central α2 agonists | Clonidine, Methyldopa, Moxonidine |
| Vasodilators | Hydralazine, Minoxidil, Diazoxide, Sodium nitroprusside |
| α1-blockers | Prazosin, Doxazosin, Terazosin |
Antiarrhythmics - Vaughan-Williams Classification
(This is one of the most asked classifications in exams)
| Class | Mechanism | Drugs |
|---|
| Ia | Na+ block (moderate) - slows phase 0, prolongs APD | Quinidine, Procainamide, Disopyramide |
| Ib | Na+ block (weak) - shortens phase 3 repolarization | Lidocaine, Mexiletine, Tocainide |
| Ic | Na+ block (strong) - markedly slows phase 0 | Flecainide, Propafenone |
| II | β-blockade - slows SA/AV node | Propranolol, Esmolol, Metoprolol |
| III | K+ channel block - prolongs repolarization | Amiodarone, Sotalol, Dofetilide, Ibutilide |
| IV | Ca2+ channel block - slows SA/AV node | Verapamil, Diltiazem |
| Unclassified | Various | Digoxin, Adenosine, Atropine, Magnesium |
Exam tips: Amiodarone has Class I + II + III + IV properties (all four classes). Sotalol = β-blocker (Class II) + K+ blocker (Class III). Quinidine causes cinchonism + torsades de pointes.
Antianginal Drugs
| Class | Drugs | Use |
|---|
| Nitrates (short-acting) | GTN (sublingual/transdermal), ISDN | Acute attack |
| Nitrates (long-acting) | Isosorbide mononitrate (ISMN), Isosorbide dinitrate (ISDN oral) | Prophylaxis |
| β-blockers | Atenolol, Metoprolol | Stable angina |
| CCBs | Amlodipine, Verapamil, Diltiazem | Vasospastic angina |
| Others | Ranolazine (late Na+ current block), Ivabradine (If channel block), Trimetazidine (metabolic) | Refractory angina |
Diuretics
| Class | Site | Drugs |
|---|
| Osmotic | PCT + Loop of Henle | Mannitol, Urea, Glycerol |
| Carbonic anhydrase inhibitors | PCT | Acetazolamide |
| Loop diuretics | Thick ascending Loop of Henle | Furosemide, Bumetanide, Torasemide, Ethacrynic acid |
| Thiazides | DCT (early) | Hydrochlorothiazide, Chlorthalidone, Indapamide |
| K+-sparing (aldosterone antagonist) | CCD | Spironolactone, Eplerenone |
| K+-sparing (ENaC blockers) | CCD | Amiloride, Triamterene |
| Aquaretics (V2 receptor antagonists) | CCD | Tolvaptan, Conivaptan |
4. ANTIMICROBIALS
Antibiotics by Mechanism
| Mechanism | Drugs |
|---|
| Cell wall synthesis inhibitors | Penicillins, Cephalosporins, Carbapenems, Monobactams, Glycopeptides (Vancomycin), Bacitracin |
| Protein synthesis (30S) | Aminoglycosides (Streptomycin, Gentamicin, Amikacin), Tetracyclines |
| Protein synthesis (50S) | Macrolides (Erythromycin, Azithromycin, Clarithromycin), Chloramphenicol, Clindamycin, Linezolid |
| DNA gyrase inhibitors | Fluoroquinolones (Ciprofloxacin, Levofloxacin, Moxifloxacin) |
| RNA polymerase inhibitors | Rifampicin |
| Cell membrane disruptors | Polymyxin B, Colistin, Daptomycin |
| DNA damage | Metronidazole, Nitrofurantoin |
| Folate synthesis inhibitors | Sulfonamides, Trimethoprim |
Cephalosporins (Generation-wise - very commonly asked)
| Generation | Anti-gram -ve | Drugs |
|---|
| 1st | Low | Cephalexin, Cefazolin, Cefadroxil |
| 2nd | Moderate | Cefuroxime, Cefaclor, Cefoxitin |
| 3rd | High | Cefotaxime, Ceftriaxone, Ceftazidime (anti-Pseudomonal) |
| 4th | Very high + antipseudomonal | Cefepime |
| 5th | MRSA active | Ceftaroline, Ceftobiprole |
Antitubercular Drugs
| Category | Drugs |
|---|
| First-line | Isoniazid (H), Rifampicin (R), Pyrazinamide (Z), Ethambutol (E), Streptomycin (S) |
| Second-line (MDR-TB) | Fluoroquinolones (Moxifloxacin, Levofloxacin), Amikacin, Capreomycin, Ethionamide, Cycloserine |
| Newer drugs | Bedaquiline, Delamanid, Pretomanid (BPaL regimen for XDR-TB) |
Side effects (exam favorite):
- Isoniazid → Peripheral neuropathy (prevented by pyridoxine B6), Hepatotoxicity, SLE-like
- Rifampicin → Orange urine/secretions, Hepatotoxicity, Enzyme inducer
- Pyrazinamide → Hyperuricemia, Hepatotoxicity
- Ethambutol → Optic neuritis (retrobulbar), colour vision loss
- Streptomycin → Ototoxicity (vestibular > cochlear), Nephrotoxicity
5. AUTACOIDS & ANTI-INFLAMMATORY DRUGS
NSAIDs - Classification
| Class | Drugs |
|---|
| Salicylates | Aspirin, Sodium salicylate, Diflunisal |
| Propionic acid derivatives | Ibuprofen, Naproxen, Ketoprofen |
| Acetic acid derivatives | Indomethacin, Diclofenac, Ketorolac, Sulindac |
| Oxicams | Piroxicam, Meloxicam, Tenoxicam |
| Fenamates | Mefenamic acid, Flufenamic acid |
| Pyrazolone derivatives | Phenylbutazone, Oxyphenbutazone |
| Selective COX-2 inhibitors (coxibs) | Celecoxib, Etoricoxib, Parecoxib, Rofecoxib (withdrawn) |
| Para-aminophenol derivative | Paracetamol (Acetaminophen) |
Histamine Antagonists
| Generation | Sedation | Drugs |
|---|
| H1 - 1st generation (sedating) | Yes | Chlorpheniramine, Diphenhydramine, Promethazine, Cyclizine, Meclizine |
| H1 - 2nd generation (non-sedating) | No | Loratadine, Cetirizine, Fexofenadine, Desloratadine, Levocetirizine |
| H2 blockers | N/A | Cimetidine, Ranitidine, Famotidine, Nizatidine |
6. ENDOCRINE PHARMACOLOGY
Insulin Types (Exam Classic)
| Type | Onset | Peak | Duration | Examples |
|---|
| Rapid-acting | 15 min | 30-90 min | 3-5 h | Lispro, Aspart, Glulisine |
| Short-acting (Regular) | 30-60 min | 2-3 h | 6-8 h | Human Regular Insulin |
| Intermediate | 1-2 h | 4-6 h | 12-18 h | NPH (Isophane) |
| Long-acting (peakless) | 2-4 h | No peak | 20-24 h | Glargine, Detemir |
| Ultra-long | 6 h | No peak | 42 h | Degludec |
Oral Hypoglycemic Agents
| Class | Mechanism | Drugs |
|---|
| Sulfonylureas (1st gen) | ↑ Insulin secretion (K+ATP close) | Tolbutamide, Chlorpropamide, Glibenclamide |
| Sulfonylureas (2nd gen) | Same + more potent | Glipizide, Gliclazide, Glimepiride |
| Biguanides | ↓ Hepatic gluconeogenesis, ↑ insulin sensitivity | Metformin |
| Thiazolidinediones (glitazones) | PPARγ agonist → ↑ insulin sensitivity | Pioglitazone, Rosiglitazone |
| Alpha-glucosidase inhibitors | Delay carb absorption | Acarbose, Miglitol, Voglibose |
| DPP-4 inhibitors (gliptins) | ↑ GLP-1 → ↑ insulin, ↓ glucagon | Sitagliptin, Vildagliptin, Saxagliptin |
| GLP-1 agonists | ↑ Insulin, ↓ glucagon, ↓ gastric emptying, weight loss | Exenatide, Liraglutide, Dulaglutide, Semaglutide |
| SGLT-2 inhibitors (gliflozins) | ↑ Urinary glucose excretion | Dapagliflozin, Empagliflozin, Canagliflozin |
| Meglitinides (glinides) | ↑ Insulin secretion (faster, shorter) | Repaglinide, Nateglinide |
7. ANTICANCER DRUGS
Classification by Mechanism
| Class | Drugs |
|---|
| Alkylating agents | Cyclophosphamide, Chlorambucil, Melphalan, Busulfan, Carmustine (BCNU), Cisplatin, Carboplatin |
| Antimetabolites - Folate antagonists | Methotrexate |
| Antimetabolites - Purine antagonists | 6-Mercaptopurine (6-MP), 6-Thioguanine, Azathioprine |
| Antimetabolites - Pyrimidine antagonists | 5-Fluorouracil (5-FU), Cytarabine (Ara-C), Gemcitabine, Capecitabine |
| Vinca alkaloids (microtubule inhibitors) | Vincristine, Vinblastine, Vinorelbine |
| Taxanes (microtubule stabilizers) | Paclitaxel, Docetaxel |
| Topoisomerase I inhibitors | Irinotecan, Topotecan |
| Topoisomerase II inhibitors | Etoposide, Teniposide, Doxorubicin, Daunorubicin |
| Antibiotics (anticancer) | Doxorubicin, Bleomycin, Dactinomycin, Mitomycin C |
| Targeted therapy - TKIs | Imatinib (BCR-ABL/CML), Gefitinib, Erlotinib (EGFR), Trastuzumab (HER2) |
| Hormonal agents | Tamoxifen (SERM, breast Ca), Anastrozole (aromatase inhibitor), Flutamide (anti-androgen) |
8. KEY EXAM MNEMONICS FROM KDT
Drugs causing SLE-like syndrome: P-SHIM - Procainamide, Sulfonamides, Hydralazine, Isoniazid, Minocycline
Enzyme inducers (↑ CYP450): PC BRAS - Phenytoin, Carbamazepine, Barbiturates, Rifampicin, Alcohol (chronic), Smoking
Enzyme inhibitors (↓ CYP450): AICE-GEK - Amiodarone, Isoniazid, Cimetidine, Erythromycin, Grapefruit juice, Etoconazole, Ketoconazole
Teratogenic drugs (Category X / high risk):
- Thalidomide, Warfarin, Methotrexate, Valproate, Phenytoin, Retinoids (Vitamin A), ACE inhibitors (2nd/3rd trimester), Aminoglycosides, Tetracyclines, Misoprostol, Diethylstilbestrol (DES)
Drugs safe in pregnancy (category B): Penicillins, Cephalosporins, Metronidazole (after 1st trimester), Paracetamol, Metformin, Labetalol, Methyldopa, Hydralazine
9. PHARMACOKINETICS CLASSIFICATION (Commonly Tested)
| Parameter | High | Low |
|---|
| Plasma protein binding | Warfarin (99%), Phenytoin (90%), Diazepam (98%) | Digoxin (25%), Lithium (0%), Aminoglycosides (10%) |
| Volume of distribution (Vd) | Chloroquine (very high), Digoxin (7 L/kg), Amiodarone (60 L/kg) | Heparin, Mannitol (plasma only) |
| T1/2 (very long) | Amiodarone (40-55 days), Chloroquine (weeks), Digoxin (36 h) | Adenosine (10 seconds), Aspirin (20 min as acetylsalicylate) |
| Renal excretion (unchanged) | Aminoglycosides, Lithium, Metformin | Lidocaine, Propranolol (hepatic) |
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics; Lippincott Illustrated Reviews: Pharmacology; Katzung's Basic & Clinical Pharmacology, 16th ed. These are equivalent reference standards to KD Tripathi's Essentials of Medical Pharmacology (9th ed.) for UG examination purposes.
Pro tip for exams: The examiner's most-asked topics from KDT are:
- Vaughan-Williams antiarrhythmic classification
- Beta-blocker cardioselectivity and ISA
- Cephalosporin generations
- Insulin types (onset/peak/duration)
- ATD side effects
- Anticancer drug classification by mechanism
- Enzyme inducers/inhibitors
- Drug receptor classification (α, β, muscarinic subtypes)